Julian Gray

734 total citations
13 papers, 528 citations indexed

About

Julian Gray is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Julian Gray has authored 13 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Julian Gray's work include Neuroscience and Neuropharmacology Research (5 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Chemical synthesis and alkaloids (3 papers). Julian Gray is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Chemical synthesis and alkaloids (3 papers). Julian Gray collaborates with scholars based in United Kingdom, Japan and United States. Julian Gray's co-authors include René Spiegel, Albert Enz, Hendrikus Boddeke, David J. Heal, Guy M. Goodwin, Hamish N. Munro, Rudy Schreiber, Robert A. McArthur, Timothy Hsu and Bruno Dubois and has published in prestigious journals such as Annals of the New York Academy of Sciences, British Journal of Pharmacology and Neuropsychopharmacology.

In The Last Decade

Julian Gray

13 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julian Gray United Kingdom 12 212 143 142 118 93 13 528
Christopher Q. Mountjoy United Kingdom 5 222 1.0× 156 1.1× 162 1.1× 68 0.6× 146 1.6× 8 591
Helen Lamb United Kingdom 9 346 1.6× 92 0.6× 298 2.1× 51 0.4× 43 0.5× 9 574
Mike F. Hawkins United States 17 371 1.8× 83 0.6× 168 1.2× 44 0.4× 93 1.0× 35 727
Michael McIlhany United States 7 169 0.8× 73 0.5× 101 0.7× 66 0.6× 94 1.0× 7 354
Spencer J. Tye United Kingdom 19 437 2.1× 95 0.7× 262 1.8× 40 0.3× 402 4.3× 26 913
Judy Zhu United States 13 327 1.5× 130 0.9× 199 1.4× 26 0.2× 94 1.0× 15 617
Sonia Torres-Sánchez Spain 11 223 1.1× 115 0.8× 123 0.9× 54 0.5× 68 0.7× 19 641
Alon Friedman Israel 2 111 0.5× 243 1.7× 202 1.4× 20 0.2× 65 0.7× 3 522
Shirley W.Y. Tsang Singapore 9 179 0.8× 114 0.8× 120 0.8× 13 0.1× 88 0.9× 10 398
Victor J. DeNoble United States 17 453 2.1× 145 1.0× 318 2.2× 28 0.2× 222 2.4× 25 728

Countries citing papers authored by Julian Gray

Since Specialization
Citations

This map shows the geographic impact of Julian Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julian Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julian Gray more than expected).

Fields of papers citing papers by Julian Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julian Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julian Gray. The network helps show where Julian Gray may publish in the future.

Co-authorship network of co-authors of Julian Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Julian Gray. A scholar is included among the top collaborators of Julian Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julian Gray. Julian Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gray, Julian, et al.. (2015). The need for thorough phase II studies in medicines development for Alzheimer’s disease. Alzheimer s Research & Therapy. 7(1). 67–67. 13 indexed citations
2.
Dubois, Bruno, Eduardo Tolosa, Regina Katzenschlager, et al.. (2012). Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study. Movement Disorders. 27(10). 1230–1238. 136 indexed citations
3.
McArthur, Robert A., Julian Gray, & Rudy Schreiber. (2010). Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials.. PubMed. 11(7). 740–60. 35 indexed citations
4.
Bacarese-Hamilton, Tito, Julian Gray, Andrea Ardizzoni, & Andrea Crisanti. (2005). Allergen Microarrays. Humana Press eBooks. 114. 195–207. 2 indexed citations
5.
Holsboer‐Trachsler, Edith, Martin Hatzinger, Rudolf Stohler, et al.. (1993). Effects of the Novel Acetylcholinesterase Inhibitor SDZ ENA 713 on Sleep in Man. Neuropsychopharmacology. 8(1). 87–92. 47 indexed citations
6.
Enz, Albert, Hendrikus Boddeke, Julian Gray, & René Spiegel. (1991). Pharmacologic and Clinicopharmacologic Properties of SDZ ENA 713, a Centrally Selective Acetylcholinesterase Inhibitor. Annals of the New York Academy of Sciences. 640(1). 272–275. 54 indexed citations
7.
Enz, Albert, Julian Gray, & René Spiegel. (1991). Muscarinic Agonists for Senile Dementia: Past Experience and Future Trends. Birkhäuser Boston eBooks. Suppl. 370–376. 26 indexed citations
8.
Hoyer, Daniël, Philippe Schoeffter, & Julian Gray. (1989). A Comparison of the Interactions of Dihydroergotamine, Ergotamine and GR 43175 with 5-HT1 Receptor Subtypes. Cephalalgia. 9(10_suppl). 340–341. 12 indexed citations
9.
Godfrey, P P, David G. Grahame‐Smith, & Julian Gray. (1988). GABAB receptor activation inhibits 5-hydroxytryptamine-stimulated inositol phospholipid turnover in mouse cerebral cortex. European Journal of Pharmacology. 152(1-2). 185–188. 27 indexed citations
10.
Gray, Julian, et al.. (1987). Increased GABABreceptor function in mouse frontal cortex after repeated administration of antidepressant drugs or electroconvulsive shocks. British Journal of Pharmacology. 92(2). 357–362. 48 indexed citations
11.
Gray, Julian, et al.. (1987). Hypothermia induced by baclofen, a possible index of GABAB receptor function in mice, is enhanced by antidepressant drugs and ECS. British Journal of Pharmacology. 92(4). 863–870. 54 indexed citations
12.
Gray, Julian, et al.. (1987). GABAB‐receptor mediated inhibition of potassium‐evoked release of endogenous 5‐hydroxytryptamine from mouse frontal cortex. British Journal of Pharmacology. 91(3). 517–522. 48 indexed citations
13.
Munro, Hamish N. & Julian Gray. (1969). The nucleic acid content of skeletal muscle and liver in mammals of different body size. Comparative Biochemistry and Physiology. 28(2). 897–905. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026